AUPO351996A0 - Viral variants and methods for detecting same - Google Patents

Viral variants and methods for detecting same

Info

Publication number
AUPO351996A0
AUPO351996A0 AUPO3519A AUPO351996A AUPO351996A0 AU PO351996 A0 AUPO351996 A0 AU PO351996A0 AU PO3519 A AUPO3519 A AU PO3519A AU PO351996 A AUPO351996 A AU PO351996A AU PO351996 A0 AUPO351996 A0 AU PO351996A0
Authority
AU
Australia
Prior art keywords
viral
present
methods
viral variants
variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO3519A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Western Health Care Network
Original Assignee
VICTORIAN INFECTIOUS DISEASES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VICTORIAN INFECTIOUS DISEASES filed Critical VICTORIAN INFECTIOUS DISEASES
Priority to AUPO3519A priority Critical patent/AUPO351996A0/en
Publication of AUPO351996A0 publication Critical patent/AUPO351996A0/en
Priority to AU37628/97A priority patent/AU734831C/en
Priority to JP52194498A priority patent/JP2001503277A/ja
Priority to ES97934385T priority patent/ES2279542T3/es
Priority to CA2270178A priority patent/CA2270178C/en
Priority to AT97934385T priority patent/ATE348880T1/de
Priority to DE69737126T priority patent/DE69737126T2/de
Priority to PCT/AU1997/000520 priority patent/WO1998021317A1/en
Priority to HK00103809.5A priority patent/HK1027374B/en
Priority to EP97934385A priority patent/EP0964916B1/en
Assigned to WESTERN HEALTH CARE NETWORK reassignment WESTERN HEALTH CARE NETWORK Amend patent request/document other than specification (104) Assignors: VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY
Assigned to WESTERN HEALTH CARE NETWORK reassignment WESTERN HEALTH CARE NETWORK Change of Name of Applicant under S 104 Assignors: VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY
Priority to US09/306,420 priority patent/US6555311B1/en
Priority to US10/260,451 priority patent/US20030124096A1/en
Priority to US10/920,462 priority patent/USRE40233E1/en
Priority to JP2008014075A priority patent/JP2008154590A/ja
Priority to US12/117,869 priority patent/US20100203506A1/en
Priority to JP2011276121A priority patent/JP2012055322A/ja
Priority to US13/547,392 priority patent/US20130171620A1/en
Priority to JP2015018686A priority patent/JP2015107127A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AUPO3519A 1996-11-08 1996-11-08 Viral variants and methods for detecting same Abandoned AUPO351996A0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
AUPO3519A AUPO351996A0 (en) 1996-11-08 1996-11-08 Viral variants and methods for detecting same
JP52194498A JP2001503277A (ja) 1996-11-08 1997-08-15 ウイルス変種およびその検出方法
HK00103809.5A HK1027374B (en) 1996-11-08 1997-08-15 Hbv mutants and methods for detecting same
EP97934385A EP0964916B1 (en) 1996-11-08 1997-08-15 Hbv mutants and methods for detecting same
ES97934385T ES2279542T3 (es) 1996-11-08 1997-08-15 Mutantes de hbv y metodos para deteccion de los mismos.
CA2270178A CA2270178C (en) 1996-11-08 1997-08-15 Viral variants and methods for detecting same
AT97934385T ATE348880T1 (de) 1996-11-08 1997-08-15 Hbv mutanten und methoden für deren nachweis
DE69737126T DE69737126T2 (de) 1996-11-08 1997-08-15 Hbv mutanten und methoden für deren nachweis
PCT/AU1997/000520 WO1998021317A1 (en) 1996-11-08 1997-08-15 Viral variants and methods for detecting same
AU37628/97A AU734831C (en) 1996-11-08 1997-08-15 Viral variants and methods for detecting same
US09/306,420 US6555311B1 (en) 1996-11-08 1999-05-06 Viral variants and methods for detecting same
US10/260,451 US20030124096A1 (en) 1996-11-08 2002-10-01 Viral variants and methods for detecting same
US10/920,462 USRE40233E1 (en) 1996-11-08 2004-08-18 Viral variants and methods for detecting same
JP2008014075A JP2008154590A (ja) 1996-11-08 2008-01-24 ウイルス変種およびその検出方法
US12/117,869 US20100203506A1 (en) 1996-11-08 2008-05-09 Viral variants and methods for detecting same
JP2011276121A JP2012055322A (ja) 1996-11-08 2011-12-16 ウイルス変種およびその検出方法
US13/547,392 US20130171620A1 (en) 1996-11-08 2012-07-12 Viral variants and methods for detecting same
JP2015018686A JP2015107127A (ja) 1996-11-08 2015-02-02 ウイルス変種およびその検出方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO3519A AUPO351996A0 (en) 1996-11-08 1996-11-08 Viral variants and methods for detecting same

Publications (1)

Publication Number Publication Date
AUPO351996A0 true AUPO351996A0 (en) 1996-12-05

Family

ID=3797830

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO3519A Abandoned AUPO351996A0 (en) 1996-11-08 1996-11-08 Viral variants and methods for detecting same

Country Status (9)

Country Link
US (4) US6555311B1 (enExample)
EP (1) EP0964916B1 (enExample)
JP (4) JP2001503277A (enExample)
AT (1) ATE348880T1 (enExample)
AU (1) AUPO351996A0 (enExample)
CA (1) CA2270178C (enExample)
DE (1) DE69737126T2 (enExample)
ES (1) ES2279542T3 (enExample)
WO (1) WO1998021317A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973367B (en) 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP706098A0 (en) * 1998-11-11 1998-12-03 North Western Health Care Network Biological compositions, components thereof and uses therefor
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AR028149A1 (es) * 1999-07-08 2003-04-30 Innogenetics Nv Deteccion de la resistencia a los farmacos contra la hepatitis b
AUPQ810900A0 (en) 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
SG90149A1 (en) * 2000-07-18 2002-07-23 Government Of The Republic Of Diagnostic assay
US6697858B1 (en) * 2000-08-14 2004-02-24 Telephony@Work Call center
US7405039B2 (en) 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
JP4502642B2 (ja) * 2002-02-07 2010-07-14 メルボルン ヘルス ヌクレオシドアナログに対する感受性の変化を有するウイルス変種およびその使用
AU2002308114A1 (en) 2002-03-29 2003-10-13 Innogenetics N.V. Hbv drug resistance drug resistance detection methods
AU2003213874B2 (en) * 2002-04-12 2008-12-04 Austin Health Hepatitis B viral variants with redused susceptibility to nucleoside analogs and uses thereof
EP2033967A1 (en) 2002-04-12 2009-03-11 Melbourne Health Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
EP2292801B1 (en) 2002-06-14 2018-08-08 Gen-Probe Incorporated Compositions and methods for detecting hepatitis b virus
US20050053916A1 (en) * 2002-10-01 2005-03-10 Korba Brent E. Diagnostic for long term response of HBV carrier to 3TC therapy
WO2006097285A1 (en) 2005-03-15 2006-09-21 Innogenetics N.V. Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
ES2470318T3 (es) 2005-03-15 2014-06-23 Rheinische Friedrich-Wilhelms-Universit�T Bonn Variantes del virus de la hepatitis B resistentes a ciertos análogos nucle�sidos, pero sensibles a otros, y usos de las mismas
US8211443B2 (en) 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
EP1874923A4 (en) 2005-04-08 2010-08-04 Melbourne Health VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF
KR100790226B1 (ko) 2005-11-03 2008-01-02 연세대학교 산학협력단 독성 간염 유발 감수성을 검출하는 방법
US20230148447A9 (en) 2008-12-11 2023-05-11 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US9175338B2 (en) * 2008-12-11 2015-11-03 Pacific Biosciences Of California, Inc. Methods for identifying nucleic acid modifications
EP2370598B1 (en) * 2008-12-11 2017-02-15 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US9611510B2 (en) 2011-04-06 2017-04-04 The University Of Chicago Composition and methods related to modification of 5-methylcytosine (5-mC)
US9238836B2 (en) 2012-03-30 2016-01-19 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing modified nucleic acids
US9175348B2 (en) 2012-04-24 2015-11-03 Pacific Biosciences Of California, Inc. Identification of 5-methyl-C in nucleic acid templates
CN115003685A (zh) * 2019-12-07 2022-09-02 Isa制药有限公司 乙型肝炎病毒相关疾病的治疗
CN115561456B (zh) * 2021-07-01 2025-10-31 黄温雅 体外定量b肝病毒大表面蛋白的套组以及用于处理肝病的生物指标组及单株抗体组

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
ZA973367B (en) * 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) * 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AUPQ810900A0 (en) * 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
US7405039B2 (en) * 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
AU2002308114A1 (en) * 2002-03-29 2003-10-13 Innogenetics N.V. Hbv drug resistance drug resistance detection methods
EP2033967A1 (en) * 2002-04-12 2009-03-11 Melbourne Health Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
JP2007509614A (ja) * 2003-10-21 2007-04-19 メルボルン ヘルス Ｈｂｖ変種の検出および適用
ES2470318T3 (es) * 2005-03-15 2014-06-23 Rheinische Friedrich-Wilhelms-Universit�T Bonn Variantes del virus de la hepatitis B resistentes a ciertos análogos nucle�sidos, pero sensibles a otros, y usos de las mismas
WO2006097285A1 (en) * 2005-03-15 2006-09-21 Innogenetics N.V. Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
EP1874923A4 (en) * 2005-04-08 2010-08-04 Melbourne Health VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF
US8211443B2 (en) * 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
CN101548014B (zh) * 2006-06-06 2012-07-04 墨尔本保健公司 抗病毒抗性突变的检测和应用

Also Published As

Publication number Publication date
ES2279542T3 (es) 2007-08-16
EP0964916B1 (en) 2006-12-20
US6555311B1 (en) 2003-04-29
JP2015107127A (ja) 2015-06-11
EP0964916A4 (en) 2001-09-26
CA2270178A1 (en) 1998-05-22
EP0964916A1 (en) 1999-12-22
CA2270178C (en) 2012-06-12
WO1998021317A1 (en) 1998-05-22
US20030124096A1 (en) 2003-07-03
JP2012055322A (ja) 2012-03-22
US20130171620A1 (en) 2013-07-04
DE69737126T2 (de) 2007-10-04
HK1027374A1 (en) 2001-01-12
JP2001503277A (ja) 2001-03-13
ATE348880T1 (de) 2007-01-15
JP2008154590A (ja) 2008-07-10
DE69737126D1 (de) 2007-02-01
US20100203506A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
AUPO351996A0 (en) Viral variants and methods for detecting same
EP0915173A3 (en) Kit and method for fluorescence based detection assay
AU6684098A (en) Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication
ID21649A (id) Inhibitor serum protease, terutama virus hepatitis c ns3 protease
ATE417275T1 (de) Puffern zur stabilizierung von hcv antigenen
HU9503219D0 (en) Methods of typing hepatitis c virus and reagents for use therein
HK1045324A1 (zh) 病毒變體
WO1996027665A3 (en) Neuron-restrictive silencer factor proteins
AU1905399A (en) Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
EP2319917A3 (en) Viral variants with altered susceptibility to nucleoside analogs and uses thereof
AU3399295A (en) Method of detecting autoantibody present in the serum of reumatic
DE69634077D1 (de) Haemophilus adhäsionsproteinen
AUPQ810900A0 (en) Viral variants and methods of using same
WO2000023477A3 (en) Immunoglobulin variants
AU636964B2 (en) Immunological detection of metolachlor
AU1334588A (en) Assay for detecting hepatitis antigens and aids antibodies
IL77862A (en) Enzymatic immunoassay to determine the amount of antibodies to htlv-iii and test kit
GB9710875D0 (en) Assay for detecting HIV antigens and HIV antibodies
GB9518440D0 (en) Sheets, kits and methods for detecting antigens or antibodies
AU2274599A (en) Adenosine detection in small samples
AU7198391A (en) Functional assay for determining the protein s activity
AU6189486A (en) Monoclonal antibodies to prosomal proteins
AU5563699A (en) Analogs of udp-murnac peptides, assays and kits
AU3829189A (en) Detecting antigens or antibodies
AU1917300A (en) Improved specificity in the detection of anti-rubella igm antibodies